Back to companies
REGENERON PHARMACEUTICALS, INC.
REGNUSNASDAQPharmaceuticals & HealthcareREGENERON PHARMACEUTICALS, INC.
Revenue
$14.3bn
YoY +1.0%
Operating income
$3.6bn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API